Jonathan Coleman, CFA
Jonathan Coleman is a Portfolio Manager on the US Small/Mid-Cap Growth Team at Janus Henderson Investors, a position he has held since 2013. From 2006 to 2013, Jonathan served as chief investment officer, equities. He joined Janus in 1994. Prior to that, he was a Fulbright Fellow in Costa Rica researching economic integration in Central America.
Jonathan received his bachelor of arts degree in political economy and Spanish from Williams College, where he graduated Phi Beta Kappa. He holds the Chartered Financial Analyst designation and has 30 years of financial industry experience.
Articles Written
A US small-cap awakening: Positive momentum for 2025
Jonathan Coleman outlines why he believes renewed strength in small caps can carry over into the new year.
Top-of-mind market risks for U.S. equities
How top-of-mind risks for our portfolio managers differ from the concerns investors worry will impact their finances in the months ahead.
Top-of-mind market risks for U.S. equities
How top-of-mind risks for our portfolio managers differ from the concerns investors worry will impact their finances in the months ahead.
Global Perspectives: Can momentum in small caps continue?
The factors driving momentum in small-cap equities and our view on what’s ahead.
U.S. small caps: Is the tide turning?
Why we could be witnessing the early stages of a change in market leadership between U.S. small cap and large cap stocks.
U.S. equities: The dawn of a new era?
Janus Henderson’s recent Global Investment Summit explored growth drivers in equities, highlighting key investment themes and opportunities across the market capitalization spectrum.
Global Perspectives: Investing in the small- and midsize healthcare companies innovating for a graying world
How healthcare’s small- and mid-cap companies could benefit from one of today’s key macroeconomic growth drivers: aging populations.
Global Perspectives: Investing in the small- and midsize healthcare companies innovating for a graying world
How healthcare’s small- and mid-cap companies could benefit from one of today’s key macroeconomic growth drivers: aging populations.
Healthcare’s small- and mid-cap opportunities amid aging populations
With populations in some of the largest economies quickly graying, innovative small- and mid-cap healthcare companies could deliver new growth opportunities for investors.
Why US small caps have potential to rebound in the new year
Jonathan Coleman says the outlook for U.S. small-cap stocks is growing stronger based on historical trends and long-term growth opportunities.